News

Vigilant Biosciences® partnered with Zer0 to 5ive to design and develop a new website dedicated exclusively to the Company’s OncAlert® Oral Cancer product line, which includes the OncAlert Oral Cancer RAPID Test and the OncAlert Oral Cancer LAB Test. These tests detect CD44 and total protein – markers clinically validated to be associated specifically with oral cancer. The test results, along with other clinical factors, can aid in the early diagnosis of oral cancer. The launch of the OncAlert website coincides with the first shipment of the product line, which is now available in select countries.